Revance Therapeutics (RVNC) EPS (2014 - 2024)
Revance Therapeutics (RVNC) EPS from Mar 31, 2014 to Sep 30, 2024. The TTM Revance Therapeutics (RVNC) EPS is -$1.96. You can adjust inflation or export chart.
Annual EPS
Quarterly EPS
Revance Therapeutics (RVNC) EPS CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | -62.09% |
| 3 Years TTM | -24.67% |
| 5 Years TTM | -12.34% |
| 10 Years TTM | -4.82% |
| All Time TTM | -3.19% |
Annual EPS change of Revance Therapeutics (RVNC)
| Year | EPS | Change |
|---|---|---|
| 2024 | -$1.30 | -65.93% |
| 2023 | -$3.83 | -21.87% |
| 2022 | -$4.90 | +17.63% |
| 2021 | -$4.17 | -14.31% |
| 2020 | -$4.86 | +32.56% |
| 2019 | -$3.67 | -6.93% |
| 2018 | -$3.94 | -1.61% |
| 2017 | -$4.01 | +26.17% |
| 2016 | -$3.18 | +5.18% |
| 2015 | -$3.02 | -6.96% |
| 2014 | -$3.24 | N/A |